As a medical device company on the edge of a major breakthrough, we get a lot of questions from people who are curious about our work and mission. We love that so many are interested in our work! We truly believe we have the technology and experience to change the world.

To make things easy for those who would like to know more about PhotoPharmics, we decided to publish a list of some of the most common questions we get, along with our answers. Enjoy!

Q: What is PhotoPharmics?

A: PhotoPharmics is a clinical-stage medical device company which has developed a specialized phototherapy device to treat neurodegenerative diseases. We are the first company with a specialized, home-use phototherapy device for people with Parkinson’s disease to receive significant recognition by the FDA as a Breakthrough Device. Our device is slated to enter a phase 3 clinical trial. We are leading the way on what could be the biggest breakthrough in Parkinson’s disease treatment in decades!

Q: What experience does the PhotoPharmics team have?

A: Our founders have more than 30 years of experience in the field of phototherapy, having previously developed specialized light solutions that are now widely used to regulate circadian rhythms in treating seasonal affective disorder (“winter blues”), sleep disorders, anxiety and depression.

Q: What is PhotoPharmics’s connection to Parkinson’s disease?

A: When it comes to Parkinson’s disease, we feel two major calls to action: First, we are using our vast experience to pioneer technology that could potentially be the biggest breakthrough in PD treatment in decades. Second, we feel a great need to raise awareness of the devastating non-motor symptoms of Parkinson’s disease which, unfortunately, rarely get discussed but can be even more life-altering than the motor symptoms.

Q: What does your device do?

A: Our specialized phototherapy device was designed to address and improve the motor and non-motor symptoms of Parkinson’s disease by stimulating regulation of the body’s natural circadian rhythm.

Q: Does it work?

A: Yes. Our phototherapy technology has been shown in clinical trials to improve the serious non-motor symptoms of PD as well as overall quality of life on top of best managed care.

Q: How does your device work?

A: Our home-use, non-invasive light therapy device uses a specialized, proprietary combination of light intensities and bandwidths to target the photoreceptors in the eye, creating a therapeutic effect to ease disease symptoms.

Q: Is your device part of any upcoming clinical trials?

A: Yes. PhotoPharmics has partnered with the Center for Health and Technology at the University of Rochester to begin a phase 3 clinical trial. It will be an at-home trial with 200 participants over six months. Participants will submit their information remotely utilizing technological innovations, opening the trial to some who would otherwise be inaccessible.

Q: Can you safely conduct a clinical trial under the conditions of a global pandemic?

A: Yes! Our trial will be conducted remotely. Each Participant will receive a device, and they will perform every function of the trial at home, including doctor visits and submitting personal results via the internet. It is a safe, non-invasive, stay-at-home trial, perfect for our time.

Q: Does the device interfere with daily life?

A: No. Research participants found the device (about the size of a laptop computer screen), to be safe and convenient to use while watching TV, reading, using a smartphone or taking part in other seated activities.

Q: Where can I learn more?

A: Sign up to be notified as more details emerge about PhotoPharmics, our specialized phototherapy device and upcoming trial information: